Griffioen M - Search Results

1

HLA-B down-regulation in human melanoma is mediated by sequences located downstream of the transcription-initiation site.

Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI. Griffioen M, et al. Int J Cancer. 1999 Feb 9;80(4):573-80. doi: 10.1002/(sici)1097-0215(19990209)80:4<573::aid-ijc15>3.0.co;2-s. Int J Cancer. 1999. PMID: 9935159

2

Establishment and characterization of an uveal-melanoma cell line.

De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, Danen EH, Jager MJ. De Waard-Siebinga I, et al. Among authors: griffioen m. Int J Cancer. 1995 Jul 17;62(2):155-61. doi: 10.1002/ijc.2910620208. Int J Cancer. 1995. PMID: 7622289 Free article.

3

C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically.

Griffioen M, Peltenburg LT, van Oorschot DA, Schrier PI. Griffioen M, et al. Immunobiology. 1995 Jul;193(2-4):238-47. doi: 10.1016/S0171-2985(11)80549-8. Immunobiology. 1995. PMID: 8530149

4

Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms.

Griffioen M, Steegenga WT, Ouwerkerk IJ, Peltenburg LT, Jochemsen AG, Schrier PI. Griffioen M, et al. Mol Immunol. 1998 Sep;35(13):829-35. doi: 10.1016/s0161-5890(98)00074-1. Mol Immunol. 1998. PMID: 9839551

5

Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines.

Griffioen M, Ouwerkerk IJ, Harten V, Gobin SJ, van den Elsen PJ, Schrier PI. Griffioen M, et al. Immunogenetics. 1999 Apr;49(4):287-94. doi: 10.1007/s002510050495. Immunogenetics. 1999. PMID: 10079292

6

Influence of increased c-Myc expression on the growth characteristics of human melanoma.

Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier PI, Pustelnik T, Eichler HG, Wolff K, Pehamberger H, Jansen B. Schlagbauer-Wadl H, et al. Among authors: griffioen m. J Invest Dermatol. 1999 Mar;112(3):332-6. doi: 10.1046/j.1523-1747.1999.00506.x. J Invest Dermatol. 1999. PMID: 10084311 Free article.

7

HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site.

Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI. Griffioen M, et al. Immunogenetics. 2000 Nov;52(1-2):121-8. doi: 10.1007/s002510000262. Immunogenetics. 2000. PMID: 11132148

8

Detection and quantification of CD8(+) T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.

Griffioen M, Borghi M, Schrier PI, Osanto S. Griffioen M, et al. Int J Cancer. 2001 Aug 15;93(4):549-55. doi: 10.1002/ijc.1361. Int J Cancer. 2001. PMID: 11477559

9

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.

Slager EH, Borghi M, van der Minne CE, Aarnoudse CA, Havenga MJ, Schrier PI, Osanto S, Griffioen M. Slager EH, et al. Among authors: griffioen m. J Immunol. 2003 Feb 1;170(3):1490-7. doi: 10.4049/jimmunol.170.3.1490. J Immunol. 2003. PMID: 12538712

10

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.

Slager EH, van der Minne CE, Goudsmit J, van Oers JM, Kostense S, Havenga MJ, Osanto S, Griffioen M. Slager EH, et al. Among authors: griffioen m. Cancer Gene Ther. 2004 Mar;11(3):227-36. doi: 10.1038/sj.cgt.7700674. Cancer Gene Ther. 2004. PMID: 14726960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters